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Background. Health care administrative database research frequently uses standard medical codes to identify diagnoses or 
procedures. The aim of this review was to establish the diagnostic accuracy of codes used in administrative data research to identify 
nontuberculous mycobacterial (NTM) disease, including lung disease (NTMLD).
Methods. We searched Ovid Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, Cochrane Central Register 
of Controlled Trials, and ClinicalTrials.gov from inception to April 2019. We included studies assessing the diagnostic accuracy of 
International Classification of Diseases, 9th edition, Clinical Modification (ICD-9-CM) diagnosis codes to identify NTM disease and 
NTMLD. Studies were independently assessed by 2 researchers, and the Quality Assessment of Diagnostic Accuracy Studies 2 tool 
was used to assess bias and quality.
Results. We identified 5549 unique citations. Of the 96 full-text articles reviewed, 7 eligible studies of moderate quality (3730 partici-
pants) were included in our review. The diagnostic accuracy of ICD-9-CM diagnosis codes to identify NTM disease varied widely across 
studies, with positive predictive values ranging from 38.2% to 100% and sensitivity ranging from 21% to 93%. For NTMLD, 4 studies re-
ported diagnostic accuracy, with positive predictive values ranging from 57% to 64.6% and sensitivity ranging from 21% to 26.9%.
Conclusions. Diagnostic accuracy measures of codes used in health care administrative data to identify patients with NTM 
varied across studies. Overall the positive predictive value of ICD-9-CM diagnosis codes alone is good, but the sensitivity is low; 
this method is likely to underestimate case numbers, reflecting the current limitations of coding systems to capture NTM diagnoses.
Keywords. accuracy; administrative data research; ICD codes; nontuberculous mycobacteria; NTM; NTMLD.
Nosology, the branch of medical science that deals with the 
classification of diseases, uses codes to standardize reporting 
of diseases. The International Classification of Diseases (ICD) 
codes endorsed by the World Health Organization are the most 
commonly used worldwide. The intention of the codes is to re-
flect the patient’s true underlying disease, but their accuracy is 
highly variable, as the code assignment process is subject to po-
tential sources of error [1–4]. These codes serve administrative 
purposes and are routinely collected and abstracted for billing 
and to file medical records or registries; they were not designed 
specifically for research. In recent years, health care adminis-
trative database research has been steadily increasing due to its 
relatively low cost. Administrative data are particularly useful 
to study rare disorders with a low incidence. Administrative 
data research relies on coded diagnoses and/or procedures [5, 
6]. However, relying on single codes or a combination to iden-
tify and accurately reflect a diagnosis can potentially lead to 
misclassification and erroneous conclusions. This has been rec-
ognized by researchers and has led to the validation of several 
codes using medical record review as the gold standard [7].
Administrative data research has been particularly useful 
for nontuberculous mycobacterial (NTM) disease due to 
its low incidence and lack of mandatory public reporting. 
Although the true prevalence of NTM disease is unknown, 
various studies have estimated changes in the prevalence of 
NTM lung disease (NTMLD), which accounts for 90% of 
NTM cases [8, 9]. US population-based surveys in the 1980s 
estimated the prevalence of NTMLD at 1–2 cases per 100 000 
persons [8]. Using data from 4 health care delivery systems, 
the average annual period prevalence for 2004–2006 was 5.5 
cases per 100  000 persons [10], and most recently a study 
using a national managed care claims database estimated 
an annual incidence of NTMLD in 2015 of 4.7 per 100 000 
person-years and an annual prevalence that year of 11.7 per 
100  000 persons [11]. The increase in prevalence reported 
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in these studies ranged from 7.5% to 8.2% per year [11, 12]. 
Because NTM disease is relatively rare and unlike tubercu-
losis, not subject to mandatory reporting in most states, our 
current understanding of the epidemiology and geographical 
distribution of these infections derives mainly from adminis-
trative data research [11–14]. With the increasing prevalence 
of NTMLD, it is foreseeable that administrative data research 
will continue to address many of the questions that remain 
unanswered, hence the importance of assessing the accuracy 
of the codes used to identify NTM disease and particularly 
NTMLD (Supplementary Table 1) [12, 13]. We aimed to 
identify studies that validated specific ICD codes or sets of 
codes for NTM disease using a reference population.
Research Question
What is the diagnostic accuracy of ICD codes or sets of codes to 
identify NTM disease?
METHODS
Data Sources and Search Strategy
A medical librarian (L.H.Y.) searched the literature for records 
including the concepts nontuberculous mycobacteria lung 
disease (NTMLD), pulmonary nontuberculous mycobacteria 
(PNTM), data, databases, and coding. The librarian created 
search strategies using a combination of keywords and stand-
ardized index terms in Ovid Medline 1946-, Embase 1947-, 
Scopus 1823-, Cochrane Database of Systematic Reviews 
(CDSR), Cochrane Central Register of Controlled Trials 
(CENTRAL), and ClinicalTrials.gov 1997–4/2019. All search 
strategies were completed in April 2019, and a total of 9988 re-
sults were found. Using Endnote, 4624 duplicate records were 
identified by the automatic duplicate finder, and another 420 
duplicates were removed manually, resulting in a total of 4944 
unique citations included in the project library. Fully repro-
ducible search strategies for each database can be found in the 
Supplementary Data. Results were updated on May 14, 2020, 
by running searches from database inception to May 14, 2020, 
then de-duplicating total results against the original results to 
find 605 new citations, to ensure capturing newly published 
manuscripts as databases do not always add content linearly. 
The PROSPERO registry was searched to corroborate that no 
systematic review was available on this topic.
Study Selection
All titles and abstracts were reviewed independently by 2 re-
searchers (C.M.C. and K.M.) for relevance to the research ques-
tion in the initial screening. To be included in the analysis, 
studies had to meet the following inclusion criteria: (1) used 
health administrative codes to identify patients with NTM dis-
ease including NTMLD, (2) had a reference data set to confirm 
the diagnosis of NTM disease, and (3) reported a measure of 
diagnostic accuracy (sensitivity, specificity, positive predic-
tive value [PPV], and/or negative predictive value [NPV]) 
of the code(s) used to identify patients with NTM disease or 
had the information available to calculate at least 1 of them. 
Manuscripts were excluded if the full-length article was not 
published in either English or Spanish and if the code(s) used 
to identify NTM was combined with the reference standard (in-
corporation bias). Inter-rater reliability analysis between the 2 
researchers (C.M.C. and K.M.) was performed with crosstabs 
and calculation of the kappa statistic using SPSS Software, ver-
sion 24 (IBM, Armonk, NY, USA).
The reference standard was defined as the data set in which 
NTM cases were confirmed using the diagnostic criteria out-
lined by the American Thoracic Society and Infectious Diseases 
Society of America (ATS/IDSA) clinical guidelines for NTM 
disease, a combination of clinical (ie, symptoms, radiological 
findings, and exclusion of other diagnoses) and microbiological 
criteria (ie, positive cultures from ≥3 separate sputum speci-
mens, single lower respiratory tract specimen or culture from 
sterile site for extrapulmonary disease) (Supplementary Table 
2) [15].
Acceptable reference standards included medical record re-
view, mandatory reported NTM surveillance registries, or a 
microbiology report data set. The test data set patients were 
identified as having NTM disease using health care administra-
tive diagnostic codes.
Data Extraction and Quality and Bias Assessment
From the full-text articles selected, the following data were ab-
stracted by 1 author (C.M.C.) using the standardized form: ci-
tation (first author, publication year, country, and sample size), 
health administrative data set (years, population characteris-
tics, and type of data), reference data set, ICD code(s) used, and 
measurements of diagnostic accuracy (Table 1).
Data were extracted from all studies that used 1 or more di-
agnostic codes to identify NTM in a data set. The primary out-
come measure was the diagnostic accuracy of the code(s) used 
to identify patients with NTM disease. As a secondary outcome, 
we examined the diagnostic accuracy of the microbiologic case 
definitions for NTMLD. The case definition for NTMLD in-
cluded microbiologic, radiographic, and clinical criteria. Most 
studies only assessed the microbiologic criteria, which are the 
most important and generally the most feasible to assess. Due to 
the heterogeneity of the data sets, study populations, and accu-
racy estimates, we did not perform a meta-analysis.
We followed the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses of Diagnostic Test Accuracy Studies 
(PRISMA-DTA) guidelines and used the Quality Assessment of 
Diagnostic Accuracy Studies 2 (QUADAS-2) checklist to as-
sess the risk of bias for each individual study (Supplementary 
Table 3) [16, 17]. The quality and risk of bias of the included 
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We used Endnote X8 (Rutgers University, New Brunswick, NJ, 
USA) to maintain the reference lists.
RESULTS
Study Characteristics
After removal of duplicate results, we identified 5549 unique 
citations. For the initial screen, articles were considered 
relevant to the research question if they referred to human 
subjects research and used health care databases, claims, 
or population-based data to identify cases of NTM disease. 
After review of the titles and abstracts, we identified 96 
citations that used claims or billing data to define cases of 
NTM disease. The inter-rater reliability between C.M.C. and 
K.M. was excellent (Kappa 0.861), and disagreement on the 
articles selected was resolved by consensus. After a review 
of titles and abstracts, 96 were selected for full-text review, 
of which 89 were excluded and 7 were selected as eligible for 
this review (Figure 1).
We identified 7 studies for full review that reported at least 1 
diagnostic accuracy measure used in an algorithm to identify 
patients with NTM disease (Table 1). Only Schweitzer’s study 
clarified in their methods the diagnostic position of the ICD 
codes used to identify patients [7]. Of the 7 full-text articles, 
4 specifically looked at NTMLD, with Plotinsky’s and Ricotta’s 
studies further limiting the study sample to only patients with 
culture-confirmed pulmonary Mycobacterium avium complex 
(MAC) disease [18]. The study population varied significantly 
among studies, and 4 of the studies used data from US veterans 
to determine the diagnostic accuracy measures and had a pre-
dominantly male and older population not representative of 
the general population. Plotinsky’s study selected patients man-
aged exclusively by Infectious Diseases or Pulmonary Medicine 
9974 citations identified through
database searching (Embase 3903,
Medline 2669, Scopus 3256, and
Cochrane 146)
14 additional records identified
through ClinicalTrials.gov
Duplicate records removed (n = 5044)
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specialists, and Schneeweiss et  al. selected only hospitalized 
patients.
Three studies used the presence of the ICD-9-CM diagnosis 
code 031.X in their algorithm to identify patients with NTM 
disease, but Jones et  al. excluded ICD-9-CM diagnosis codes 
031.8 and 031.9 (not specific to NTM). Four studies only used 
ICD-9-CM diagnosis code 031.0 (pulmonary NTM). Of the 
4 studies that relied solely on ICD-9-CM diagnosis codes to 
screen patients for inclusion in their cohort, 3 did full chart re-
view on the whole cohort and Jones et al. used a randomized 
sample to serve as the reference data set. Winthrop et al. used ei-
ther positive microbiological cultures or an ICD-9-CM code to 
identify eligible patients for their cohort, whereas Prevots’s and 
Ricotta’s studies used culture results to establish theirs. Prevots’s 
reference data set also lacked clinical data to fully assess ATS/
IDSA NTM diagnostic criteria as the gold standard, and instead 
used only microbiological (≥2 sputum samples positive for an 
NTM spp. or a single positive culture from a bronchoscopy) and 
radiological criteria (available in 81% of the cohort) to verify 
NTM disease.
Primary Outcome: Validity of the Codes Used to Identify NTM Disease
Algorithms and diagnostic accuracy outcomes to identify NTM 
disease using ICD-9-CM diagnosis codes varied across studies, 
with sensitivity ranging from 21% to 93% and PPV ranging from 
38.2% to 100% (Tables 1 and 2). The sole use of ICD-9-CM code 
031.0 by Ricotta et al. also yielded a low sensitivity (21%). Only 
2 studies reported diagnostic accuracy for the combination of 
ICD-9-CM codes plus microbiological data vs the ICD-9-CM 
code alone. In Winthrop’s VA cohort (n = 71), sensitivity de-
creased when ≥1 culture positive for NTM spp. was required 
together with the ICD-9 code 031.X (65% vs 42%). However, 
Jones et al. found a substantial increase in sensitivity with the 
use of microbiological data or the ICD-9-CM diagnosis code 
compared with the ICD-9-CM diagnosis code alone (93% vs 
42.9%, respectively), although the increase in the PPV of using 
both was only modest (54.3% vs 38.2%). However, PPVs of 
ICD-9-CM codes alone to identify NTM cases were consistently 
higher in Schneeweiss et  al. (70%), Schweitzer et  al. (64.6%), 
and Winthrop et al. (74%–82%). In Winthrop et al., when both 
microbiological and ICD-9-CM codes were used, the PPV was 
similar to that of using the ICD-9-CM code alone (77%–90%).
Jones and colleagues reported the specificity and NPV of 
using ICD-9 codes to identify NTM cases; both were >99.9% 
[14]. Only Winthrop’s study looked at the diagnostic accuracy 
of incorporating prescriptions of drugs used to treat NTM in-
fections in their algorithm. The combination of an ICD-9-CM 
code plus ≥30 days of a macrolide prescription had the highest 
PPV (100%) to identify NTM cases. Also, 1 of the cohorts of 
patients included in Winthrop’s study included only patients 
with rheumatoid arthritis, limiting the generalizability of their 
results.
Secondary Outcome: Validity of the Codes Used to Identify NTMLD
Four studies provided diagnostic accuracy measures for using 
the ICD-9-CM code 031.0 to identify NTMLD, with sensitivity 
ranging from 21% to 26.9% and PPV ranging from 57% to 64.6% 
(Table 1). The lowest sensitivity was seen in Ricotta’s study, in 
which those with disease that was microbiologically confirmed 
and those with an ICD-9-CM code were compared with the ref-
erence standard. This is consistent with previously published 
data that only 27% of microbiologically confirmed cases are 
coded for NTMLD, suggesting substantial undercoding of this 
diagnosis in health care administrative data [19].
Quality Assessment of Studies
The quality of the diagnostic accuracy studies included was 
assessed using the revised QUADAS-2 tool across 4 domains: 
patient selection, index test, reference standard, and flow 
and timing. The overall risk of bias in patient selection was 
judged to be low, as all but 1 article included consecutive cases 
and there were no inappropriate patient exclusions (Table 3). 
Plotinsky et al. only included patients who had been seen by a 
Pulmonologist or an Infectious Diseases specialist. In terms of 
flow and timing, there was a low risk of bias, given the retro-
spective nature of the studies and that the accuracy of identi-
fication using ICD-9-CM codes was compared with the same 
reference standard, the ATS/IDSA diagnostic criteria for NTM 
infection. However, 2 studies may be at risk of bias with regard 
to interpretation of the reference standard because they used 1 
or 2 of 3 components of the reference standard instead of the full 
criteria. Ricotta and colleagues used only the microbiological 
culture criteria of the ATS/IDSA criteria as their gold standard 
to define NTM infection, whereas Prevots et al. lacked data on 
the clinical component in their reference data set, and only 81% 
of their cohort had radiological information. However, micro-
biological data have the highest PPV of the 3 criteria.
One of the major risks for bias is the applicability of studies 
that broadly used the entire range of ICD-9-CM codes 031.X for 
NTM infection and did not differentiate coding for dissemin-
ated infection (ICD-9-CM code 031.2) from the NTMLD code 
031.0. The underlying predisposing risk factors and prognosis 
of disseminated vs NTMLD are quite distinct, with dissemin-
ated NTM being an acute and potentially life-threatening con-
dition more frequently encountered in the hospital setting and 
NTMLD being an indolent, chronic condition often seen in the 
ambulatory setting. Indeed, coding accuracy tends to be lower 
in the outpatient setting [20]. Another potential source of bias 
is the position of the diagnostic code (ie, primary vs secondary 
diagnosis), which was specified in only 1 of the studies included 
in the final review. There is evidence that many comorbidities 
tend to be underreported and that omission rates for coding of 
secondary diagnoses are higher in the outpatient setting [21]. 
This is often related to a limited number of codes that can re-
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To our knowledge, this is the first systematic review to sum-
marize the published literature on the diagnostic accuracy of 
ICD-CM codes to identify patients with NTM infections in 
health care administrative databases. Of the 7 studies that met 
eligibility criteria, only 3 had among their aims to validate the 
ICD-9-CM code for NTM infection against a reference data 
set. The rest of the studies reported at least 1 diagnostic accu-
racy measure for such codes as a secondary measure. Overall, 
the sensitivity of ICD codes in NTM infections was low 
(<50%) in 3 of the 4 studies that provided this measure, with 
the highest sensitivity (65%) seen in a cohort of US veterans. 
The highest sensitivity (93%) and specificity (>99.9%) to detect 
NTM cases, seen in Jones et al. study, were achieved through 
an algorithm involving either ICD-9-CD codes (031.0, 031.1, 
or 031.2) or microbiology results obtained via natural language 
processing to identify NTM species, a novel approach to obtain 
information about NTM cultures. These findings reflect sub-
stantial undercoding of NTM infections in which patients need 
to meet clinical, microbiological, and often radiological cri-
teria to establish an NTM diagnosis. It is unclear why the Jones 
study produced the lowest PPV, but exclusion of ICD-9 codes 
031.8 and 031.9 could have left out true infections that were 
erroneously coded through the patient’s trajectory through the 
health care encounter [1]. Also, low PPV of a single ICD-CM 
code(s) assigned at discharge has been described in other in-
fections in which microbiological or radiological confirmation 
to establish a diagnosis is more complicated (eg, cellulitis) [4], 
something that might impact identification of NTM infec-
tions, where there is typically a time delay between sampling 
collection and culture positivity due to the slow-growing na-
ture of NTM.
The different populations included in each study may limit 
the generalizability of their results. Jones et al. and Schneeweiss 
and colleagues exclusively looked at US Veterans Affairs pa-
tients, and in Winthrop et  al. and Schweitzer and colleagues’ 
cohorts, US veterans represented more than 50% of the patients. 
This overrepresentation of the US veteran population does not 
reflect the general population, as veterans tend to be older, to 
have a higher prevalence of comorbidities, and are predomi-
nately male [22], limiting the external validity of these studies. 
This is important, given that the prevalence of NTM infection 
seems to be higher among females in almost all age groups 
[23]. The low sensitivity of the ICD-9-CM code 031.0 reported 
by Ricotta et  al., who used the Premier Healthcare Database, 
a billing database that includes privately and publicly insured 
patients and also uninsured patients, may be more representa-
tive of the general US population. None of the studies included 
Medicare data to validate the screening algorithms to identify 
patients with NTM infections, an important population given 
that the prevalence of NTM infections, particularly NTMLD, 
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70 years [23]. However, the population included in all studies 
was primarily older, supporting the observed findings.
There are several limitations to our review. First, the general-
izability of the findings described in most studies is limited to 
that of the population being studied, which in half of the studies 
included only US veterans. Second, none of the studies included 
ICD-10-CM codes for NTM infections. Therefore, a validation 
cohort study assessing the sensitivity and specificity of the ICD-
10-CM code A31.X by investigating a random selection of a large 
number of inpatient and outpatient medical records should be 
undertaken in the future to clarify the diagnostic accuracy of 
that code. Third, only 1 study alluded to the differences in the 
diagnostic coding field location (primary, secondary, or all), a 
relevant source of misclassification, as comorbidities tend to be 
underreported and omission rates for coding of secondary diag-
noses tend to be higher in the outpatient setting [20]. Finally, risk 
of misclassification with regard to the reference standard was 
high in 2 studies that did not use the full ATS/IDSA diagnostic 
criteria, primarily due to the lack of clinical or radiological data.
In conclusion, ICD-9-CM codes alone have poor sensitivity 
for identifying confirmed NTM cases, potentially missing a rel-
evant number of NTM cases and thereby underestimating the 
prevalence of this disease, but they are commonly used because 
they are more readily available compared with microbiological 
data. However, their good PPV is reassuring, as research done on 
populations identified using ICD-9CM codes will most likely ob-
tain relevant clinical conclusions applicable to patients with NTM 
infection. The composite use of microbiological data and ICD-
9-CM codes may increase sensitivity without meaningfully chan-
ging the PPV, an approach that should be favored if culture data 
are available. Although accuracy of diagnoses based on claims 
data may have potential bias due to patient misclassification, 
given the low, albeit increasing prevalence of NTM infections, 
use of health care administrative data sets remains appealing and 
advantageous to estimate epidemiological trends and examine 
mortality outcomes. Future studies are needed to address the ac-
curacy of these codes in different health care settings (inpatient vs 
outpatient), code positions (primary vs secondary), administra-
tive databases (eg, Medicaid), and ICD-10-CM systems.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility 
of the authors, so questions or comments should be addressed to the 
corresponding author.
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